Woodford on: Lloyds, Barclays, RBS, Astra and Glaxo

Neil Woodford reveals he's recently bought stakes in Barclays and RBS and speaks about his holdings in Lloyds and AstraZeneca, plus why he dumped GlaxoSmithKline

David Brenchley 10 November, 2017 | 2:46PM
Facebook Twitter LinkedIn

Neil Woodford has recently bought stakes in RBS and Barclays.

It’s no secret that Neil Woodford has had a “disappointing” year so far. He’s admitted as much himself. His trio of fund offerings have underperformed both their benchmarks and sector averages.

The star fund manager has taken big hits on what were some of his highest conviction ideas. His stake in Provident Financial (PFG) has plummeted 70% in less than five months. His holding in the AA (AA.) has slumped 40% year-to-date.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
AstraZeneca PLC8,710.00 GBP0.00Rating
Barclays PLC175.02 GBP0.00Rating
GlaxoSmithKline PLC1,419.00 GBP0.00Rating
HSBC Holdings PLC359.75 GBP0.00Rating
LF ASI Income Focus A Sterling Acc69.57 GBP1.09Rating
LF Equity Income C Sterling Acc3.45 GBP0.00
Lloyds Banking Group PLC43.78 GBX3.07Rating
NatWest Group PLC206.10 GBP-0.34Rating
Provident Financial PLC321.41 GBP-0.49
Schroder UK Public Private Trust Ord31.90 GBP-0.92Rating

About Author

David Brenchley

David Brenchley  is a Reporter for Morningstar.co.uk

© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement